Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

The mouse model of oxygen-induced retinopathy (OIR) has been widely used in studies related to retinopathy of prematurity, proliferative diabetic retinopathy and in studies evaluating the efficacy of antiangiogenic compounds. In this model, 7-d-old (P7) mouse pups with nursing mothers are subjected to hyperoxia (75% oxygen) for 5 d, which inhibits retinal vessel growth and causes significant vessel loss. On P12, mice are returned to room air and the hypoxic avascular retina triggers both normal vessel regrowth and retinal neovascularization (NV), which is maximal at P17. Neovascularization spontaneously regresses between P17 and P25. Although the OIR model has been the cornerstone of studies investigating proliferative retinopathies, there is currently no harmonized protocol to assess aspects of angiogenesis and treatment outcome. In this protocol we describe standards for mouse size, sample size, retinal preparation, quantification of vascular loss, vascular regrowth, NV and neovascular regression.

[1]  Michael I Dorrell,et al.  Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis , 2007, Proceedings of the National Academy of Sciences.

[2]  Alan W. Stitt,et al.  Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. , 2005, The American journal of pathology.

[3]  P. Hardy,et al.  Hypercapnia prevents neovascularization via nitrative stress. , 2006, Free radical biology & medicine.

[4]  C. Stewart,et al.  Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. , 2008, The Journal of clinical investigation.

[5]  M. Chopp,et al.  Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.

[6]  Donald E. Ingber,et al.  A mechanosensitive transcriptional mechanism that controls angiogenesis , 2009, Nature.

[7]  Holger Gerhardt,et al.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.

[8]  Perinatal ocular physiology and ROP in the experimental animal model , 1990, Documenta Ophthalmologica.

[9]  J. Flynn,et al.  Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1991, Ophthalmology.

[10]  M. R. Powers,et al.  MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy. , 2008, Investigative ophthalmology & visual science.

[11]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[12]  Karen W. Miller,et al.  Incidence and Early Course of Retlnonathy of Prematurity , 1991 .

[13]  C. Lange,et al.  Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. , 2007, Experimental eye research.

[14]  R W Flower,et al.  Postnatal retinal vascular development of the puppy. , 1985, Investigative ophthalmology & visual science.

[15]  P. Carmeliet,et al.  Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration , 2009, Pediatric Research.

[16]  Lois E. H. Smith,et al.  IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth , 2007, Proceedings of the National Academy of Sciences.

[17]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[18]  Michael I Dorrell,et al.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.

[19]  Lois E. H. Smith,et al.  Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. , 2009, Investigative ophthalmology & visual science.

[20]  J. Penn,et al.  Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. , 1994, Investigative ophthalmology & visual science.

[21]  Lois E. H. Smith,et al.  Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.

[22]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Ashton,et al.  Role of Oxygen in the Genesis of Retrolental Fibroplasia , 1953, The British journal of ophthalmology.

[24]  N. Ashton.  Animal experiments in retrolental fibroplasia. , 1954, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.

[25]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[26]  D. Hinton,et al.  Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization , 2005, Laboratory Investigation.

[27]  K. Yu,et al.  Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. , 1999, Current eye research.

[28]  R. Douglas,et al.  Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  G. Almazan,et al.  Selective Neuromicrovascular Endothelial Cell Death by 8-Iso-Prostaglandin F2&agr;: Possible Role in Ischemic Brain Injury , 2003, Stroke.

[30]  A. Madan,et al.  Animal models of oxygen-induced retinopathy. , 2003, Frontiers in bioscience : a journal and virtual library.

[31]  Lois E. H. Smith,et al.  Essential role of growth hormone in ischemia-induced retinal neovascularization. , 1997, Science.